INY-03-041 trihydrochloride
Product Specifications
Target
Akt, PROTACs
Related Pathways
Cytoskeletal Signaling, PROTAC, PI3K/Akt/mTOR signaling
Bioactivity
INY-03-041 trihydrochloride, a potent and highly selective PROTAC-based pan-AKT degrader, comprises Ipatasertib, an ATP-competitive AKT inhibitor, conjugated to Lenalidomide. It effectively inhibits AKT1, AKT2, and AKT3 with IC50 values of 2.0, 6.8, and 3.5 nM, respectively [1].
Molecular Formula
C44H59Cl4N7O5
Molecular Weight
907.8
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC681457-500 1x 500 µL
PDCD1 / PD1 / CD279 (Programmed Cell Death 1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
![ZNF500 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1F5]](https://cdn.genprice.uk/products/937/6868c3bb994c49e6dc3fd2cc/imageurl/ta803350bm.webp)
TA803350BM 100 µL
ZNF500 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1F5]
Sign In for Pricing
View Details 
LC419655 20 µg
Decorin (DCN) (NM_001920) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC680771-500 1x 500 µL
P27 / KIP1 (DCS-72.F6), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details